SCHEMBL8565841

SCHEMBL8565841

N#Cc1cccc(CN2CCC(N3C(=O)Nc4ccccc4C3c3ccccc3)CC2)c1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 3/20 0.56
DRD4 P21917 3/20 0.52
DRD3 P35462 2/20 0.47
DRD2 P14416 1/20 0.47
CCR3 P51677 1/20 0.44
FAAH O00519 1/20 0.43
OPRL1 P41146 1/20 0.42
OPRM1 P35372 1/20 0.42
TACR1 P25103 1/20 0.42
THRB P10828 1/20 0.42
CHRM2 P08172 2/20 0.41
CHRM4 P08173 1/20 0.41
MLNR O43193 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165224 0.90 OPRM1 (0.52) CHRM3DRD4FAAHOPRL1OPRM1
SCHEMBL6168606 0.88 OPRL1 (0.52) CHRM3DRD4DRD3DRD2OPRL1
SCHEMBL29445321 0.88 OPRL1 (0.52) CHRM3DRD4DRD3DRD2OPRL1
SCHEMBL8564439 0.86 CHRM2 (0.55) CHRM3DRD4DRD3DRD2OPRL1
SCHEMBL8569557 0.85 CHRM2 (0.54) CHRM3DRD4DRD3DRD2OPRL1
SCHEMBL8570520 0.85 OPRL1 (0.45) CHRM3DRD4DRD3DRD2OPRL1
SCHEMBL8562946 0.85 CHRM3 (0.54) CHRM3OPRL1OPRM1CHRM2
SCHEMBL8565541 0.85 CHRM2 (0.54) CHRM3OPRL1CHRM2
SCHEMBL8571871 0.85 CHRM3 (0.54) CHRM3DRD3DRD2OPRL1OPRM1
SCHEMBL6164748 0.85 OPRL1 (0.44) CHRM3DRD2OPRL1OPRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed